Physician's hand on the international normalized ratio level of vitamin K antagonist

Physician's hand on the international normalized ratio level of vitamin K antagonist

Bibliographic Details
Main Authors:	Wei‐Ta Chen, Ming‐Hsiung Hsieh
Format:	Article
Language:	English
Published:	Wiley 2019-08-01
Series:	Journal of Arrhythmia
Online Access:	https://doi.org/10.1002/joa3.12186

Similar Items

Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist
by: S. I. Farag, et al.
Published: (2020-09-01)

The international normalized ratio (INR) as seen in a population of patients with atrial fibrillation and cerebral infarction undergoing long-term treatment with vitamin K antagonists
by: Szczepańska-Szerej Anna, et al.
Published: (2015-12-01)

Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey
by: Claudio Cimminiello, et al.
Published: (2018-08-01)

Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry
by: Hee‐Soon Park, et al.
Published: (2019-08-01)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
by: Frederique E. C. M. Peeters, et al.
Published: (2018-10-01)

International Normalized Ratio Response Subsequent to Modest Increase in Vitamin K Intake in Patients Treated with Warfarin
by: Mona Foroughi, et al.
Published: (2016-05-01)

Reflex regulation of antagonist muscles in the normal human hand
by: Carter, Randy Ray
Published: (1990)

Vitamin K antagonists after all, or possibly not?
by: Victor Machado Gil
Published: (2016-09-01)

Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
by: Giovanni Luca Botto, et al.
Published: (2021-06-01)

The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
by: Kuang-Tsu Yang, et al.
Published: (2021-12-01)

Multivariate relationships between international normalized ratio and vitamin K-dependent coagulation-derived parameters in normal healthy donors and oral anticoagulant therapy patients
by: Golanski Jacek, et al.
Published: (2003-11-01)

Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage
by: Szu-Ju Chen, et al.
Published: (2020-01-01)

Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonists
by: Arianna Magon, et al.
Published: (2020-03-01)

Non-vitamin K Antagonist Oral Anticoagulants: Practise Essentials
by: Joana de Lemos Barata Garcia
Published: (2019)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
by: Mark Terence P. Mujer, et al.
Published: (2020-01-01)

Extent of arterial calcification by conventional vitamin K antagonist treatment.
by: Selma Hasific, et al.
Published: (2020-01-01)

Non-vitamin K antagonist oral anticoagulants for heart diseases
by: T B Kondratieva, et al.
Published: (2017-09-01)

Strain differences in toxicity of vitamin K antagonist warfarin in rats
by: Đokić Jelena, et al.
Published: (2013-01-01)

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
by: Emma Kirstine Laugesen, et al.
Published: (2019-11-01)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01)

Vitamin K antagonist use and renal function in pre-dialysis patients
by: Voskamp PWM, et al.
Published: (2018-05-01)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
by: Anne-Sophie Dincq, et al.
Published: (2014-01-01)

Non-Vitamin K Antagonist Oral Anticoagulants: A Concise Guide
by: Shantsila, Eduard
Published: (2016)

The impact of acute diarrhea on the coagulation status of patients with vitamin K antagonists
by: Johannes Schweinfurth, et al.
Published: (2021-06-01)

Vitamin K and Bone Health: A Review on the Effects of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters
by: Celia Rodríguez-Olleros Rodríguez, et al.
Published: (2019-01-01)

International Normalized Ratio (INR)
by: Azhar Hassan Shirazi
Published: (2007-06-01)

Self-monitoring treatment programme with oral vitamin K antagonists in paediatric patients
by: Rubén Berrueco, et al.
Published: (2018-12-01)

1.2 VASCULAR CALCIFICATIONS AFTER CHRONIC USE OF VITAMIN-K ANTAGONISTS
by: B.J. van Varik, et al.
Published: (2009-12-01)

Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding.
by: Paola E J van der Meijden, et al.
Published: (2013-01-01)

THE DEVELOPMENT OF THE EXPERIMENTAL MODEL OF PERIODONTITIS OF RATS IN CONDITIONS OF THE ACTION OF THE ANTAGONIST OF VITAMIN K
by: Anna Nikolaeva
Published: (2015-11-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
by: Barcellona D, et al.
Published: (2018-08-01)

The HIPOGAIA study: Monitoring of oral anticoagulation with vitamin K antagonists in the municipality of Gaia
by: Marta Guedes, et al.
Published: (2016-09-01)

Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
by: Joong Hyun Park, et al.
Published: (2018-12-01)

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance
by: El-Helou N, et al.
Published: (2013-03-01)

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
by: Fernando Pivatto Júnior, et al.
Published: (2014-06-01)

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
by: Giuseppe Santarpia, et al.
Published: (2015-01-01)

Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study
by: Lihong Tang, et al.
Published: (2020-06-01)

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
by: Daniele Pastori, et al.
Published: (2018-04-01)

Anticoagulants in clinical practice. The place of vitamin K antagonists in combination with new oral anticoagulants
by: T. V. Vavilova
Published: (2015-12-01)